Physician

Matthew Michael Reimert, M.D.

According to 2025 Medicare claims, Matthew Reimert, M.D. (NPI: 1215269014) practices rheumatology in the Santa Cruz-Watsonville, CA market, with the plurality of this provider's patient population coming from Santa Cruz, CA. This provider's primary affiliated billing organization is SUTTER BAY MEDICAL FOUNDATION (NPI: 1013950807; TIN: 941156581) and primary practice location at 95062-1323. Reimert is affiliated with the Sutter Medicare Direct (ACO ID: A5279), participating under the MSSP model.

Reimert's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 480 traditional Medicare patients, billed 14,730 HCPCS/CPT codes, and received $350,100 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 2,135 prescription claims across 393 beneficiaries totaling $2,947,039 in drug costs, led by Enbrel Sureclick (Etanercept). No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $115,260 to $350,100. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $476,207 to $2,947,039. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	410	3,508	$115,260
2016	441	4,039	$122,419
2017	592	5,044	$159,760
2018	559	5,257	$162,545
2019	473	5,434	$157,621
2020	395	4,652	$129,943
2021	422	6,007	$194,489
2022	413	7,576	$219,735
2023	488	11,704	$304,769
2024	480	14,730	$350,100

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	266	1,554	$476,207
2016	304	1,794	$656,509
2017	379	2,062	$930,766
2018	418	2,492	$1,984,430
2019	416	2,622	$2,196,593
2020	343	2,568	$2,322,629
2021	375	2,495	$2,435,786
2022	425	2,588	$2,667,250
2023	420	2,510	$3,004,017
2024	393	2,135	$2,947,039

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	56	56	$162
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	406	1,060	$98
J0897	Injection, denosumab, 1 mg	80	8,340	$21
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	355	856	$13
96372	Injection of drug or substance under skin or into muscle	84	169	$13

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Enbrel Sureclick	Etanercept	79	2,238	$600,410
Humira(Cf) Pen	Adalimumab	40	1,120	$262,283
Taltz Autoinjector	Ixekizumab	29	1,092	$251,281
Enbrel Mini	Etanercept	25	700	$173,724
Enbrel	Etanercept	22	616	$168,159

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for Matthew Michael Reimert, M.D.?

Tedicare shows public-source Medicare data for Matthew Michael Reimert, M.D. (NPI 1215269014), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Matthew Michael Reimert, M.D. have ACO affiliation data?

Matthew Michael Reimert, M.D. is shown with ACO affiliation data for Sutter Medicare Direct (MSSP, ACO ID A5279).

What billing organization is linked to Matthew Michael Reimert, M.D.?

Matthew Michael Reimert, M.D. is linked to SUTTER BAY MEDICAL FOUNDATION (billing NPI 1013950807) in the available physician profile data.

Does Matthew Michael Reimert, M.D. have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.